{"id":56102,"date":"2026-05-14T13:52:13","date_gmt":"2026-05-14T13:52:13","guid":{"rendered":"https:\/\/my.legal500.com\/developments\/?post_type=press_releases&#038;p=56102"},"modified":"2026-05-14T13:52:13","modified_gmt":"2026-05-14T13:52:13","slug":"lutz-abel-advises-shareholders-of-plasmion-on-sale-to-shimadzu","status":"publish","type":"press_releases","link":"https:\/\/my.legal500.com\/developments\/press-releases\/lutz-abel-advises-shareholders-of-plasmion-on-sale-to-shimadzu\/","title":{"rendered":"LUTZ | ABEL ADVISES SHAREHOLDERS OF PLASMION  ON SALE TO SHIMADZU"},"content":{"rendered":"<p>Munich, April 2026<\/p>\n<p><strong>LUTZ | ABEL advised the shareholders of Plasmion GmbH, including, inter alia, the founders Dr. Jan-Christoph Wolf and Dr. Thomas Wolf, HTGF, BayBG and Wieland Capital on the sale of a 75% stake in the company to Shimadzu Corporation, a global leader in analytical and measuring instruments headquartered in Japan.<\/strong><!--more--><\/p>\n<p>With this transaction, Shimadzu strengthens its presence in the field of advanced analytical technologies and expands its portfolio in innovative mass spectrometry solutions. Plasmion, an Augsburg-based technology company, is known for its pioneering developments in ion mobility spectrometry, particularly its SICRIT\u00ae technology, which enables rapid and highly sensitive chemical analysis.<\/p>\n<p>The LUTZ | ABEL team was led by <strong>Philipp Hoene<\/strong> (lead partner, Munich) and included <strong>Constanze Hachmann<\/strong> (Hamburg), <strong>Lars Dieball<\/strong> (Munich) and <strong>Frank Hahn<\/strong> (Hamburg, all M&amp;A), as well as <strong>Cornelius Renner<\/strong> (IP\/IT, Berlin). The firm advised the sellers on all legal aspects of the transaction, including structuring, negotiation and execution.<\/p>\n<p>Founded in 2013, Plasmion has established itself as an innovation leader in the field of compact and efficient ionization technologies. Its solutions are used in a wide range of applications, including environmental analysis, food safety, and pharmaceutical research. Through the partnership with Shimadzu, Plasmion aims to accelerate its international growth and further develop its cutting-edge technology platform.<\/p>\n<p>Shimadzu Corporation, listed on the Tokyo Stock Exchange, is a globally active provider of precision<br \/>\ninstruments, medical equipment and industrial machinery.<\/p>\n<p><strong>About LUTZ | ABEL<\/strong><br \/>\nLUTZ | ABEL as a law firm, with approximately 110 attorneys and offices in Munich, Hamburg, Stuttgart, Berlin, and Frankfurt am Main, provides advice on all matters of commercial law.<\/p>\n<p>For more information, please visit www.lutzabel.com.<\/p>\n<p><strong>Contact LUTZ | ABEL<\/strong><\/p>\n<p>Philipp Hoene<br \/>\nPartner<br \/>\n+49 89 544147-0<br \/>\nhoene@lutzabel.com<\/p>\n<p>Anne Hofmann<br \/>\nHead of Marketing &amp; Business Development<br \/>\n+49 40 3006996-7701<br \/>\nhofmann@lutzabel.com<\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-56102","press_releases","type-press_releases","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/press_releases\/56102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/press_releases"}],"about":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/types\/press_releases"}],"wp:attachment":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/media?parent=56102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}